Contrast-enhanced liver ultrasound is used when doctors need a clearer look at a spot or mass seen in the liver, especially when a standard ultrasound cannot show what it is. A small amount of contrast containing tiny gas bubbles is injected into a vein, helping the radiologist watch blood flow through the area. This can help distinguish many noncancerous from cancerous growths and show whether more tests are needed.
Contrast-enhanced ultrasound (CEUS) is a problem-solving imaging test, not a routine test needed for every liver finding. The clinician chooses it based on what earlier images show, the location and size of the area, the person's medical history, and whether ultrasound can answer the question clearly enough. Availability, local approval of contrast agents, and radiology expertise also influence whether the test is offered.
What makes contrast-enhanced liver ultrasound different?
A standard liver ultrasound uses sound waves to create pictures of the liver and surrounding structures. It can identify many abnormalities, but some spots are difficult to classify from their appearance alone. CEUS adds an injected contrast agent made of tiny gas-filled bubbles. These bubbles travel through the bloodstream and reflect ultrasound waves, allowing the radiologist to observe how blood reaches and moves through a particular area.
According to RadiologyInfo.org, this technique helps clinicians examine abnormalities in organs and blood vessels. Unlike CT scans, ultrasound does not use X-rays. The contrast agent used for CEUS is also different from the iodine-based contrast commonly used for CT and the gadolinium-based contrast used for many MRI examinations.
During the examination, the radiologist observes the lesion's blood-flow and contrast-enhancement patterns over time. These patterns can provide clues about the type of tissue involved and whether a finding is more consistent with a benign growth or a potentially cancerous one. The images are interpreted alongside previous scans and other relevant clinical information.
When do doctors recommend contrast-enhanced liver ultrasound?
When a routine ultrasound finds an unclear liver spot
One of the main reasons to perform CEUS is to investigate a focal liver lesion. A focal lesion is an area that looks different from the surrounding liver tissue. It may be discovered during an ultrasound performed for an unrelated reason or as part of an examination for a known liver condition.
The finding may represent a benign growth, such as a hemangioma, or another type of lesion that needs closer evaluation. Sometimes the appearance on a standard scan is not specific enough to determine the likely explanation. Cleveland Clinic explains that contrast can make lesions identified on a standard liver ultrasound easier to see and assess.
CEUS may help the radiologist characterize the finding and decide whether it has a typical benign appearance or needs further investigation. Not every liver lesion requires contrast imaging; the decision depends on the original finding and the clinical question.
When CT or MRI results do not fully explain a lesion
Sometimes a lesion remains uncertain after CT or MRI, or it is not well demonstrated on those examinations. CEUS may provide additional information about its blood supply and enhancement pattern. It can be particularly useful when the area can be clearly seen with ultrasound but its nature remains uncertain on other imaging studies.
CEUS may also be considered when a person has a medical reason to avoid a particular CT or MRI contrast agent. Because ultrasound contrast agents have different ingredients and properties, they may be suitable for some people who have kidney disease or a history of reactions to other imaging contrast agents. The radiology team must still assess the person's medical history and the specific agent being considered.
When a person has an increased risk of primary liver cancer
People with certain chronic liver conditions, including cirrhosis or chronic hepatitis B, may undergo regular liver imaging because their risk of hepatocellular carcinoma (HCC), a primary liver cancer, is increased. If imaging identifies a lesion that needs further assessment, CEUS may help characterize it in appropriate cases.
RadiologyInfo.org's guide to the Liver Imaging Reporting and Data System (LI-RADS) explains that specialized radiologists can use CEUS to assess liver lesions in selected patients. The interpretation depends on the person's risk factors and the imaging findings. CEUS is not necessary for every person undergoing liver cancer surveillance, and it does not replace all other recommended examinations.
When doctors need to assess the response to liver cancer treatment
CEUS may be used after certain treatments for a known liver tumor, including treatments that destroy a lesion with heat or other local techniques. By examining contrast enhancement in and around the treated area, the radiologist may be able to assess whether additional evaluation is needed.
Follow-up imaging may use CEUS, CT, MRI, or a combination of methods, depending on the treatment and the clinical question. The choice also depends on whether ultrasound can adequately show the treated area. A contrast-enhanced ultrasound result is interpreted with the treatment history and earlier images rather than in isolation.
Can contrast-enhanced liver ultrasound be used in children?
Yes. CEUS can be used to evaluate focal liver lesions in children when the examination is appropriate and the contrast agent is approved for that use. The U.S. prescribing information for Lumason, available through DailyMed, includes characterization of focal liver lesions in both adult and pediatric patients. Approval and clinical practice may differ by country and by contrast product, so pediatric examinations are planned according to local requirements and specialist assessment.
What happens during the examination?
CEUS is usually performed in a hospital or imaging center. The sonographer or radiologist first uses a standard ultrasound probe to locate the area being examined. Gel is placed on the skin, and the probe is moved over the abdomen to obtain images of the liver.
A small intravenous line is used to inject the contrast agent. The radiologist then watches the selected area as the contrast moves through its blood supply. Additional images or injections may be needed to evaluate more than one lesion. The examination usually involves little discomfort beyond the pressure of the probe and the brief needle insertion.
Preparation depends on the facility and the reason for the scan. Some people may be asked not to eat for several hours beforehand, while others need little or no special preparation. Follow the instructions provided by the imaging center, including guidance on food, drinks, and regular medicines.
What are the benefits and limitations of CEUS?
CEUS provides real-time information about blood flow without exposing the person to ionizing radiation. It can sometimes answer a specific question about a liver lesion without the need for another imaging examination. It may also be useful when certain CT or MRI contrast agents are unsuitable, although the advantages must be weighed against the person's medical history and the information needed.
However, CEUS does not answer every liver-imaging question. According to RadiologyInfo.org, some lesions are difficult to examine when they are very small, deep within the liver, or close to the lungs. Body tissues and bowel gas can also limit the quality of ultrasound images. The examination may therefore be unable to provide a clear answer in some cases.
CEUS generally focuses on a specific area rather than providing the same broad view of the body as some CT or MRI examinations. When doctors need to assess the full extent of a cancer, examine other organs, or investigate findings that ultrasound cannot adequately show, additional imaging may still be necessary. Occasionally, a biopsy or another follow-up test is recommended.
Is the contrast used for liver ultrasound safe?
Most people tolerate ultrasound contrast agents well, but they are not entirely free of risk. Reactions can include nausea or headache, and allergic reactions are possible. Serious reactions are uncommon, but they can occur. Safety precautions depend on the specific contrast product used.
The prescribing information for Lumason on DailyMed warns about uncommon serious cardiopulmonary and hypersensitivity reactions. It also lists known hypersensitivity to the product's ingredients, including polyethylene glycol (PEG), as a contraindication. Tell the imaging team about previous reactions to contrast agents, known allergies, and significant heart or lung conditions before the examination. The team will determine whether the planned agent is appropriate and take the required precautions.
What happens after the scan?
A radiologist reviews the images and prepares a report for the clinician who requested the examination. The report may describe a lesion's appearance and enhancement pattern, explain whether the findings are consistent with a likely benign lesion, or state that further evaluation is needed. The result is then considered alongside the person's medical history and previous imaging.
Depending on the findings, the next step may be no further testing, routine imaging follow-up, another scan such as MRI or CT, or a biopsy. An inconclusive result does not automatically mean cancer; sometimes the images simply do not provide enough detail to classify the lesion confidently. The ordering clinician can explain what the report means and why any additional testing is being recommended.